Skip to main content
Fig. 5 | BMC Cancer

Fig. 5

From: BRAF mutant colorectal cancer: ErbB2 expression levels as predictive factor for the response to combined BRAF/ErbB inhibitors

Fig. 5

ErbB2/HER2/Neu is differentially expressed in untreated BRAF V600E CRC cell lines. a Representative immunoblots with (b) densitometric quantification of band intensities show ErbB2/HER2/Neu) protein levels in the three cell lines. (Loading control: HSP70) Bars in (B) represent means ± SD of three independent experiments. Statistics (test used): ** p < 0.01 vs. Colo205 cells

Back to article page

BMC Cancer

ISSN: 1471-2407

Contact us